ANDA 87562, held by Idt Australia Ltd. Dipyridamole.
As of Nov 16, 2026, ANDA 87562 (Dipyridamole), held by Idt Australia Ltd, was first approved by FDA on Feb 25, 1992, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 25, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dipyridamole50MG ยท tablet;oral | Dipyridamole | Discontinued |
| Feb 25, 1992 | Original application | Approved | None posted |
| Feb 25, 1992 | Supplement 18Labeling | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters